A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
UCL Enterprise Strategy
2 November 2011
Following the publication of the UCL Enterprise Strategy, many people have been struck by the significance of the UCL commitment to supporting the development of 500 new businesses over the next five years.
This has led to some great news coverage of our vision in Science Business and our commitment to supporting student-led companies in the Sunday Times. UCL is also recognised as a university that provides it’s students with an introduction to real business skills.
The strategy document is also available in hard copy. Please email firstname.lastname@example.org if you would like a copy sent to you.